Midttun Mette, Overgaard Karsten, Zerahn Bo, Pedersen Maria, Rashid Anahita, Østergren Peter Busch, Paulin Tine Kolenda, Pødenphanth Thea Winther, Karlsson Linda Katharina, Rosendahl Eva, Ragle Anne-Mette, Vinther Anders, Rasmussen Rune Skovgaard
Medical Department O, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
Neurological Department N, University Hospital of Copenhagen, Herlev Hospital, Herlev, Denmark.
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1451-1462. doi: 10.1002/jcsm.13498. Epub 2024 Jun 18.
Due to increasing older populations worldwide, injuries, disabilities and deaths caused by falls among the elderly represent a growing human and societal problem. We aimed to improve health among men of at least 70 years of age with low-normal to low testosterone and mobility problems by using testosterone undecanoate (TU) injections, progressive strength training, and oral supplements of vitamin D, calcium and protein.
This was a single-centre, randomized, placebo-controlled, double-blind trial with 148 older men with a median age of 77 (73-81) years, testosterone levels at median 8 (5-9) nmol/L (full range from 1.1 to 12.9 nmol/L) and mobility problems, recruited at University Hospital of Copenhagen, Herlev Hospital, Denmark. Participants were randomized into four arms for 20 weeks: (1) TU therapy (n = 37); (2) progressive resistance training with supplements of calcium, vitamin D and protein (n = 36); (3) both interventions combined (n = 36); or (4) no intervention (n = 39). The main outcome measure was the 30-s chair stand test, due to test performance correlating with the risk of serious fall injuries and lower extremity muscle strength. Outcome measurements were performed at baseline and after 20 weeks.
After the intervention, the combination group receiving progressive resistance training, TU and supplements achieved a median score of 13 (11-15) compared to the control group at 10 (0-14) in the 30-s chair stand test (P = 0.003). This median improvement of 3.0 was clinically important. Compared to the control group, participants in the combination group also increased quality of life (P < 0.05) and reduced both tiredness (P < 0.05) and leg fat (P < 0.05) and had higher variability in the RR interval (P < 0.01). The group receiving TU reduced gynoid and leg fat compared to the control group (both P < 0.05). Blood tests improved for several variables, especially in the combination group. There was no statistically significant increase in adverse effects from either the supplements or training.
In men ≥70 years old with low-normal to low testosterone and mobility problems, supplements of testosterone, calcium, vitamin D and protein combined with progressive resistance training improved 30-s chair stand test performance, muscle strength and quality of life. Both tiredness and leg fat were reduced, and RR interval variability was increased. Significant adverse effects were not observed.
由于全球老年人口不断增加,老年人跌倒造成的伤害、残疾和死亡成为日益严重的人类和社会问题。我们旨在通过注射十一酸睾酮(TU)、进行渐进性力量训练以及口服维生素D、钙和蛋白质补充剂,改善年龄至少70岁、睾酮水平处于低正常至低水平且存在行动不便问题的男性的健康状况。
这是一项单中心、随机、安慰剂对照、双盲试验,纳入了148名年龄中位数为77(73 - 81)岁、睾酮水平中位数为8(5 - 9)nmol/L(范围为1.1至12.9 nmol/L)且存在行动不便问题的老年男性,他们在丹麦哥本哈根大学医院赫勒夫医院招募。参与者被随机分为四组,为期20周:(1)TU治疗组(n = 37);(2)补充钙、维生素D和蛋白质的渐进性抗阻训练组(n = 36);(3)两种干预措施联合组(n = 36);或(4)无干预组(n = 39)。主要结局指标是30秒椅子站立测试,因为测试表现与严重跌倒伤害风险和下肢肌肉力量相关。结局测量在基线和20周后进行。
干预后,接受渐进性抗阻训练、TU和补充剂的联合组在30秒椅子站立测试中的中位数得分为13(11 - 15),而对照组为10(0 - 14)(P = 0.003)。这3.0的中位数改善具有临床意义。与对照组相比,联合组的参与者生活质量也有所提高(P < 0.05),疲劳感(P < 0.05)和腿部脂肪(P < 0.05)均有所减少,并且RR间期变异性更高(P < 0.01)。与对照组相比,接受TU治疗的组腹部和腿部脂肪减少(均P < 0.05)。多项血液检测指标有所改善,尤其是在联合组。补充剂或训练均未导致不良反应有统计学意义的增加。
在年龄≥70岁、睾酮水平低正常至低水平且存在行动不便问题的男性中,补充睾酮、钙、维生素D和蛋白质并结合渐进性抗阻训练可改善30秒椅子站立测试表现、肌肉力量和生活质量。疲劳感和腿部脂肪均减少,RR间期变异性增加。未观察到明显的不良反应。